BMX — BioMaxima SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapHigh Flyer

Annual income statement for BioMaxima SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	PAS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	61.6	81.1	146	47.7	53.9
Cost of Revenue
Gross Profit	23.9	32.1	57.7	22.6	26.1
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	52.2	68.1	111	47	52.6
Operating Profit	9.4	13	34.9	0.728	1.31
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	8.75	12.8	35.9	0.187	0.306
Provision for Income Taxes
Net Income After Taxes	7.33	10.2	28.9	0.586	0.535
Minority Interest
Net Income Before Extraordinary Items
Net Income	7.36	10.2	28.9	0.586	0.535
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	7.36	10.2	28.9	0.586	0.535
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.8	2.41	6.48	0.029	0.123
Dividends per Share